In This Article:
Japan's stock markets have shown resilience, with the Nikkei 225 and TOPIX indices experiencing notable gains this week, buoyed by a historic weakening of the yen which has favored export-heavy industries. In such an environment, growth companies with high insider ownership like PeptiDream can be particularly compelling, as they often combine deep market knowledge with a vested interest in driving long-term value.
Top 10 Growth Companies With High Insider Ownership In Japan
Name | Insider Ownership | Earnings Growth |
SHIFT (TSE:3697) | 35.4% | 26.8% |
Kanamic NetworkLTD (TSE:3939) | 25% | 28.9% |
Hottolink (TSE:3680) | 27% | 57.4% |
Medley (TSE:4480) | 34% | 28.7% |
Micronics Japan (TSE:6871) | 15.3% | 39.8% |
Kasumigaseki CapitalLtd (TSE:3498) | 34.8% | 44.6% |
ExaWizards (TSE:4259) | 24.8% | 91.1% |
AeroEdge (TSE:7409) | 10.7% | 28.5% |
Soracom (TSE:147A) | 17.2% | 54.1% |
freee K.K (TSE:4478) | 24% | 72.9% |
Here we highlight a subset of our preferred stocks from the screener.
PeptiDream
Simply Wall St Growth Rating: ★★★★★☆
Overview: PeptiDream Inc. is a biopharmaceutical company focused on the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics, with a market capitalization of approximately ¥322.85 billion.
Operations: The company generates revenue primarily from the development of therapeutic peptides and small molecule drugs.
Insider Ownership: 26.1%
Earnings Growth Forecast: 22.3% p.a.
PeptiDream, a Japanese biotech firm, shows promise with its high insider ownership and growth trajectory. Recent strategic expansions with Novartis and innovative clinical studies, like the first-in-human imaging study for ccRCC diagnosis using 64Cu-PD-32766, underscore its potential in precision medicine. Financially, PeptiDream has revised its earnings guidance upwards significantly for 2024, reflecting robust operational performance and optimistic revenue prospects from ongoing collaborations. However, the company's profit margins have decreased compared to the previous year.
-
Navigate through the intricacies of PeptiDream with our comprehensive analyst estimates report here.
-
Our expertly prepared valuation report PeptiDream implies its share price may be too high.
Rakuten Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Rakuten Group, Inc. operates in e-commerce, fintech, digital content, and communications sectors serving a diverse customer base both in Japan and globally, with a market capitalization of approximately ¥1.78 trillion.
Operations: The company generates revenue through its operations in online retail, financial services, digital media, and telecommunications.